Sanara MedTech Inc Aktie News

Poised for U.S. market launch in Q1 2027 following the achievement of recent milestones and OsStic's granted patent in 2025 FORT WORTH, TX, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce h...

SMTI's surgical segment revenue grew 22% year-over-year in Q3 to $26.3 million. Surgical segment adjusted EBITDA was $4.9 million, at a margin of 18.6%. Following a strategic review, management has decided to discontinue the THP segment despite significant investments that were made.

ATLANTA, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Sanara MedTech Inc. (“Sanara” or “the Company”) (NASDAQ: SMTI) complied with federal securities laws. On November 11, 2025, Sanara announced that “the Company initiated a strategic realignment of its business, discontinuing operations of [Tissue Health Plus] to improve its operating efficiency and reallocat...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON SANARA MEDTECH INC. (SMTI), CLI...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN SANARA MEDTECH INC. (SMTI), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAI...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON SANARA MEDTECH INC. (SMTI), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOS...

FORT WORTH, TX, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, announced today that management will participate in the Piper Sandler 37th An...

Sanara MedTech Inc. ( SMTI ) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Company Participants Seth Yon - President, CEO & Director Elizabeth Taylor - Chief Financial Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald & Co., Research Division Daniel Journey Yi Chen - H.C. Wainwright & Co, LLC, Research Division Presentation Operator Welcome to the Sanara MedTech Third Q...